Register by May 7
Join West Virginia Clinical and Translational Science Institute leadership and members from across the state to discuss exciting new efforts and initiatives in clinical and translational science in the Mountain State.
This day-and-a-half event will feature: WVCTSI progress and highlights, research roundtable discussions, presentations from team science headliners, innovation and commercialization pitches in the WVCTSI Shark Tank, poster presentations from exciting work across the CTS spectrum, updates on available resources and services for members, and breakout sessions on key topics and trends.
This meeting will also feature a keynote address from Sten Vermund, M.D., Ph.D., Dean and Anna M.R. Lauder Professor of Public Health at Yale School of Public Health and professor of pediatrics at the Yale School of Medicine.
The meeting will be held May 16 – 17 at the Morgantown Marriott at Waterfront Place in Morgantown, West Virginia. Deadline to register for this event is 11:59 p.m. EST on Monday, May 7. Additional information and registration can be found on the event webpage.
Cervical cancer can be insidious. Changes to the cervix are often detected with a pap smear, but for those with limited access to health care, cervical and vaginal cancers can go unnoticed for years—silently growing, spreading and invading other organs—and by the time they’re detected, they may be so advanced that the patient’s prognosis is poor and her treatment options few. Valerie Galvan Turner, a gynecologic oncologist at the West Virginia University Cancer Institute, has opened a randomized clinical trial to assess whether a novel supplemental treatment can help chemotherapy and radiation fight these dangerous forms of cancer better.